]H+5=,O4BJ+GTS>OB1EJNWU|^X
SYSTEM PROCESSING...
]H+5=,O4BJ+GTS>OB1EJNWU|^X
SYSTEM PROCESSING...
Posted: 2025-04-14 10:58:44 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-14 10:59:21 UTC
Verified By
Rollup News
Pfizer has halted the development of its obesity pill following safety concerns, specifically liver injury, which poses a significant setback to the company's strategic efforts to recover post-Covid.
Drug development
Pharmaceutical industry
Obesity treatment
Pfizer's strategic goals
Patient safety
Safety issues in drug development
Liver injury as a side effect
Setbacks in post-Covid recovery strategy
Competition in the obesity treatment market